David Zaccardelli | CEO |
Mark Hahn | CFO |
Kathy Rickard | CMO |
Chris Martin | VP, Commercial |
Joon Lee | Truist Securities |
Suji Jeong | Jefferies |
Tom Shrader | BTIG |
Edward Nash | Canaccord Genuity |
Welcome to the Verona Pharma Third Quarter 2020 Financial Results and Operating Highlights Conference Call. At this time, all participants are in a listen-only mode. Earlier this morning, Verona Pharma issued a press release about its financial results for the three and nine months ended September 30, 2020. A copy can be found in the Investor Relations tab on the corporate website www.veronapharma.com.
Before we begin, I would like to remind you that during today’s call statements about the Company’s future expectations, plans, and prospects are forward-looking.